News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Novartis
NEWS
JOBS
IN THE PRESS
NEWS
Business
Novartis AG Lures Superstar Scientist Away From UCSF
August 17, 2017
·
3 min read
Deals
Novartis AG Boss Updates Q2 Financials and Reaffirms M&A Strategy
July 19, 2017
·
3 min read
Business
Novartis AG’s Long-Suffering Alcon Sees Sales Growth in Q2, Opening Door to Spin-Off IPO
July 18, 2017
·
1 min read
Novartis AG Stocking Up on “Big-3" Arthritis Blockbusters to Get an Edge on Rivals
July 14, 2017
·
2 min read
FDA
FDA Panel Unanimously Endorses Novartis AG’s CAR-T Leukemia Drug
July 13, 2017
·
3 min read
Policy
Novartis AG Avoided Deaths In CAR-T Trials But Long-Term Safety Is Key, Says The FDA
July 11, 2017
·
1 min read
Policy
Waiting Lists are Already Forming for Novartis AG and Kite Pharma’s Not-Yet Approved CAR-T Drugs
July 7, 2017
·
3 min read
Drug Development
Can Merck & Co. And Novartis AG’s Surprise Heart Drug Success Translate To Blockbuster Sales?
June 29, 2017
·
1 min read
Job Trends
Novartis AG Rejects Trump’s Proposition to Create More U.S Jobs
June 21, 2017
·
3 min read
AWARDS
JOBS
Currently, there are no jobs for this company on BioSpace
Browse all jobs
here
Oops!
There was an issue retrieving the jobs list. Please reload the page to view more jobs.
Title
Location
Company Name
Desc
View details
IN THE PRESS
Press Releases
Novartis receives European Commission approval for Itvisma® for spinal muscular atrophy (SMA)
July 2, 2026
·
7 min read
Press Releases
Antares Therapeutics Enters Agreement with Novartis to Discover, Develop and Commercialize First-in-Class Cancer Therapies
June 24, 2026
·
2 min read
Press Releases
Novartis Canada and SP Quebec Celebrate 16 Years of Partnership Through Annual MS Tri-Challenge Fundraiser
June 24, 2026
·
4 min read
Press Releases
FiberSense Continuous Glucose Monitoring (CGM) System obtains CE mark as commercial launch preparations begin
June 17, 2026
·
2 min read
Press Releases
Novartis RemIND data at EAACI show Rhapsido® potential as first targeted therapy for chronic inducible urticaria (CIndU)
June 12, 2026
·
11 min read
Press Releases
Novartis delpacibart braxlosiran (del-brax) Phase I/II study in facioscapulohumeral muscular dystrophy (FSHD) meets primary biomarker endpoint
June 11, 2026
·
8 min read
Press Releases
Orionis Biosciences Announces Strategic Collaboration with Novartis to Discover and Develop Molecular Glue Medicines
June 10, 2026
·
2 min read
Press Releases
Novartis to highlight Rhapsido® data across multiple immune-mediated diseases at EAACI Congress 2026
June 8, 2026
·
6 min read
Press Releases
Novartis IgAN data in The Lancet show clinically meaningful slowing of kidney function decline with Vanrafia® over 2.5 years
June 4, 2026
·
11 min read
Press Releases
Novartis Cosentyx® PMR data in New England Journal of Medicine showed sustained remission vs placebo in twice as many patients
June 4, 2026
·
10 min read
